Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Johnson and Johnson
Boehringer Ingelheim
Dow
AstraZeneca

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,621,891

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,621,891
Title:Method and apparatus for delivering epinephrine
Abstract:A method of administering liquid medicine such as epinephrine to a patient includes administering a first dose followed by administering an optional second dose is described herein. Also described herein are devices useful for carrying out the methods described and kits containing these devices.
Inventor(s): Wyrick; Ronald (Spokane, WA)
Assignee: Washington Biotech Corporation (Spokane, WA)
Application Number:11/276,460
Patent Claim Types:
see list of patent claims
Formulation; Delivery; Device;

Drugs Protected by US Patent 7,621,891

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Impax TWINJECT 0.15 epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020800-002 May 28, 2004 DISCN No No   Start Trial   Start Trial Y   Start Trial
Impax TWINJECT 0.3 epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020800-001 May 30, 2003 DISCN No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,621,891

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005314174   Start Trial
Australia 2005314401   Start Trial
Brazil PI0518415   Start Trial
Brazil PI0518460   Start Trial
Canada 2585707   Start Trial
Canada 2589899   Start Trial
Canada 2826821   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Harvard Business School
Mallinckrodt
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.